Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Palleon Pharmaceuticals

Palleon Pharmaceuticals
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$47.6M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer. The company's biotechnology platform integrates technologies and insights from scientific leaders all over the world in the fields of glycoscience and human immunology to create a novel approach to treating cancer by targeting multiple immune cell types, providing physicians with a wider range of rational combination therapies to treat cancer and tackle resistance to first-generation immuno-oncology agents.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 266 Second Avenue
  • Waltham, MA 02451
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Palleon Pharmaceuticals’s full profile, request a free trial.

Palleon Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 04-Oct-2017 $47.6M 000.00 000.00 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Palleon Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 000
To view this company’s complete Cap Table, request access »

Palleon Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
SR One Corporate Venture Capital Minority 000 0000 000000 0
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0
Vertex Ventures HC Venture Capital Minority 000 0000 000000 0

Palleon Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
James Broderick MD Co-Founder, Chief Executive Officer & Board Member
Li Peng Ph.D Chief Scientific Officer
Paul Crocker Ph.D Co-Founder
Carolyn Bertozzi Ph.D Co-Founder

Palleon Pharmaceuticals Board Members (10)

Name Representing Role Since Contact
Info
James Broderick MD Palleon Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Jayson Punwani Ph.D Self Board Member 000 0000
Jens Eckstein Ph.D SR One Board Member 000 0000
Lori Hu Vertex Ventures HC Board Member 000 0000
Margarita Chavez JD AbbVie Ventures Board Observer 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »